{"url_path":"/sec/pbm/10-k/2026/item-16g","section_key":"item-16g","section_title":"Item 16G CORPORATE GOVERNANCE","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-06-22","source_url":"https://www.sec.gov/Archives/edgar/data/1985062/0001213900-26-070607-index.html","accession_number":"0001213900-26-070607","cik":"0001985062","ticker":"PBM","issuer_name":"PSYENCE BIOMEDICAL LTD.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1985062/0001213900-26-070607-index.html","primary_entity_key":"0001985062","primary_entity_name":"PSYENCE BIOMEDICAL LTD."},"word_count":29,"has_tables":true,"body_markdown":"** **\n\nITEM 16G. CORPORATE GOVERNANCE\n\n \n\nThe information set forth in Item 6B above\nunder the caption *“Corporate Governance Practices and Foreign Private Issuer Status”* is incorporated herein by reference.\n\n** **\n\n83"}